Skip to main content
. Author manuscript; available in PMC: 2021 Nov 1.
Published in final edited form as: Am J Cardiol. 2020 Aug 15;134:130–137. doi: 10.1016/j.amjcard.2020.07.062

Table 1:

Baseline characteristics of veterans diagnosed with pulmonary hypertension.

Variable Total Cohort (n=110,495) Diabetes Absent (n=70,455; 63.8%) Diabetes Present (n=40,040; 36.2%)
Age at PH diagnosis (years) 70.2 [62.1, 79.6] 71.2 [61.9, 80.7] 68.9 [62.4, 77.5]
Age categories (years)
<60 20,900 (18.9%) 14,085 (20.0%) 6,815 (17.0%)
60–70 33,825 (30.6%) 19,259 (27.3%) 14,566 (36.4%)
70–80 29,414 (26.6%) 17,931 (25.5%) 11,483 (28.7%)
>80 26,356 (23.9%) 19,180 (27.2%) 7,176 (17.9%)
Male 106,562 (96.4%) 67,556 (95.9%) 39,006 (97.4%)
Race
White 82,236 (74.4%) 52,435 (74.4%) 29,801 (74.4%)
Black 18,558 (16.8%) 11,397 (16.2%) 7,161 (17.9%)
Other 1,866 (1.7%) 1,111 (1.6%) 755 (1.9%)
Missing 7,835 (7.1%) 5,512 (7.8%) 2,323 (5.8%)
Presumed PH group
PAH 8,835 (8.0%) 6596 (9.4%) 2,239 (5.6%)
PH, left heart disease 17,813 (16.1%) 10,735 (15.2%) 7,078 (17.7%)
PH, lung disease 18,375 (16.6%) 14,189 (20.1%) 4,186 (10.5%)
CTEPH 1,561 (1.4%) 1,288 (1.8%) 273 (0.7%)
PH, misc causes 309 (0.3%) 218 (0.3%) 91 (0.2%)
Multiple causes of PH 63,602 (57.6%) 37,429 (53.1%) 26,173 (65.4%)
Any heart disease 78,135 (70.7%) 45,653 (64.8%) 32,482 (81.1%)
Any lung disease 80,112 (72.5%) 50,407 (71.5%) 29,705 (74.2%)
Weight (kg) 89.5 [75.3, 108] 84.5 [71.7, 101] 99.7 [83.8, 119]
Missing 494 (0.4%) 385 (0.5%) 109 (0.3%)
BMI (kg/m2) 28.9 [24.7, 34.5] 27.4 [23.7, 32.2] 32.0 [27.3, 37.8]
Missing 3,265 (3.0%) 2,405 (3.4%) 860 (2.1%)
BMI category (kg/m2)
< 18.5 2,570 (2.3%) 2,376 (3.4%) 194 (0.5%)
18.5–24.9 25,930 (23.5%) 20,721 (29.4%) 5,209 (13.0%)
25.0–29.9 31,331 (28.4%) 21,314 (30.3%) 10,017 (25.0%)
≥ 30 47,399 (42.9%) 23,639 (33.6%) 23,760 (59.3%)
Missing 3,265 (3.0%) 2,405 (3.4%) 860 (2.1%)
Weight change in 3 years prior to PH
>5% loss 22,598 (20.5%) 13,797 (19.6%) 8,801 (22.0%)
1–5% loss 19,250 (17.4%) 11,687 (16.6%) 7,563 (18.9%)
<1% change 10,307 (9.3%) 6,164 (8.7%) 4,143 (10.3%)
1–5% gain 15,782 (14.3%) 9,054 (12.9%) 6,728 (16.8%)
>5% gain 15,779 (14.3%) 8,640 (12.3%) 7,139 (17.8%)
Missing 26,779 (24.2%) 21,113 (30.0%) 5,666 (14.2%)
Weight change in 3 years prior to PH (%) −1.0 [−5.4, 3.5] −1.2 [−5.6, 3.1] −0.6 [−5.2, 4.0]
Missing 26,779 (24.2%) 21,113 (30.0%) 5,666 (14.2%)
BNP (pg/mL) 368 [127, 886] 369 [120, 911] 368 [137, 860]
Missing 61,983 (56.1%) 41,671 (59.1%) 20,312 (50.7%)
Creatinine (mg/dL) 1.20 [0.92, 1.50] 1.10 [0.90, 1.40] 1.30 [1.00, 1.77]
Missing 5,627 (5.1%) 4,012 (5.7%) 1,615 (4.0%)
Sodium (mEq/L) 139 [136, 141] 139 [137, 141] 139 [136, 141]
Missing 4,762 (4.3%) 3,590 (5.1%) 1,172 (2.9%)
Hemoglobin A1c (%)
Mean (SD) 6.73 (1.37) 5.98 (0.844) 7.34 (1.41)
Median [IQR] 6.40 [5.80, 7.35] 5.90 [5.50, 6.30] 7.10 [6.36, 8.03]
Missing 42,633 (38.6%) 40,168 (57.0%) 2,465 (6.2%)
Died 70,976 (64.2%) 44,393 (63.0%) 26,583 (66.4%)

BMI: body mass index; BNP: brain natriuretic peptide; CTEPH: chronic thromboembolic pulmonary hypertension; PH: pulmonary hypertension; PAH: pulmonary arterial hypertension. Notes: 1. Comorbid diagnoses listed are those present prior to or within 6 months after PH diagnosis. Laboratory, weight and BMI data are those values present within 6 months before to 6 months after PH diagnosis and if multiple values were available for a given patient, the median was taken. Values given are the median [25th, 75th percentile] unless specifically noted. Comparison between those with and without diabetes was performed using t-tests and Chi-square tests for continuous and categorical data, respectively. Comparing the groups with and without diabetes, all variables were statistically different (P<0.001) except for BNP (P=0.25).